Vijay Patel - 18 Oct 2024 Form 3 Insider Report for Kintara Therapeutics, Inc. (HURA)

Role
10%+ Owner
Signature
/s/ Dan Dearborn as Power of Attorney for Vijay Patel
Issuer symbol
HURA
Transactions as of
18 Oct 2024
Net transactions value
$0
Form type
3
Filing time
22 Oct 2024, 20:50:14 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KTRA Common Stock 7,999,557 18 Oct 2024 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KTRA Warrants 18 Oct 2024 Common Stock 3,049,432 $3.69 See Footnote F1, F2
holding KTRA Warrants 18 Oct 2024 Common Stock 1,315,441 $5.70 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), among the Issuer (fka "Kintara Therapeutics, Inc."), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer ("Merger Sub"), and TuHURA Biosciences, Inc., a Delaware corporation ("Private TuHURA"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the "Merger") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to "TuHURA Biosciences, Inc."
F2 The shares are owned by K&V Investment One, LLC, an entity over which the reporting person has beneficial ownership through his position as sole manager.

Remarks:

See Exhibit 24 - Power of Attorney.